At Asha Therapeutics, we are utilizing a unique mito-centric approach to develop treatments for neurodegenerative diseases, including Parkinson’s Disease, Alzheimer’s Disease, Myalgic Encephalomyelitis, and Chronic Fatigue Syndrome.

Asha Therapeutics is advancing a new paradigm of drug discovery by re-engineering cellular machinery towards restoring the powerhouse of the cell. We are leveraging our extensive experience in medicinal chemistry, computational drug design, and neurobiology to address pathological dysregulation and restore cellular homeostasis.